- Home
- WOLF vs BCYC Comparison
WOLF vs BCYC Comparison
Compare WOLF & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOLF
- BCYC
- Stock Information
- Founded
- WOLF 1987
- BCYC 2009
- Country
- WOLF United States
- BCYC United Kingdom
- Employees
- WOLF N/A
- BCYC N/A
- Industry
- WOLF Semiconductors
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- WOLF Technology
- BCYC Health Care
- Exchange
- WOLF Nasdaq
- BCYC Nasdaq
- Market Cap
- WOLF 1.6B
- BCYC 1.7B
- IPO Year
- WOLF 1993
- BCYC 2019
- Fundamental
- Price
- WOLF $7.95
- BCYC $15.59
- Analyst Decision
- WOLF Hold
- BCYC Buy
- Analyst Count
- WOLF 16
- BCYC 9
- Target Price
- WOLF $17.21
- BCYC $36.00
- AVG Volume (30 Days)
- WOLF 12.8M
- BCYC 880.7K
- Earning Date
- WOLF 01-29-2025
- BCYC 10-31-2024
- Dividend Yield
- WOLF N/A
- BCYC N/A
- EPS Growth
- WOLF N/A
- BCYC N/A
- EPS
- WOLF N/A
- BCYC N/A
- Revenue
- WOLF $804,500,000.00
- BCYC $36,898,000.00
- Revenue This Year
- WOLF N/A
- BCYC $40.52
- Revenue Next Year
- WOLF $42.33
- BCYC N/A
- P/E Ratio
- WOLF N/A
- BCYC N/A
- Revenue Growth
- WOLF 4.96
- BCYC 48.60
- 52 Week Low
- WOLF $6.10
- BCYC $12.17
- 52 Week High
- WOLF $47.43
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- WOLF 42.67
- BCYC 37.83
- Support Level
- WOLF $9.13
- BCYC $12.17
- Resistance Level
- WOLF $8.52
- BCYC $21.50
- Average True Range (ATR)
- WOLF 0.91
- BCYC 1.36
- MACD
- WOLF -0.05
- BCYC -0.36
- Stochastic Oscillator
- WOLF 7.01
- BCYC 49.67
About WOLF Wolfspeed Inc.
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.